BioEconomy Marketplace

The Processes and Products of the US biomanufacturing community


January Feature Products:

Microbial Optimization Tools

Inscripta®, a life science company located in Pleasanton, California, provides a portfolio of cutting-edge gene editing tools and technologies to help advance the bioeconomy. In 2019, Inscripta® launched the bench-top CRISPR-based gene editing platform, ONYX® which enables rapid custom alterations of genomic DNA. For biomanufacturing R&D purposes these tools are useful for accelerating the strain optimization process. To maximize scale-up efficiency, Inscripta's next generation gene-editing technology, GenoScaler® platform, boasts the potential of developing commercially compliant strain with >10,000x productivity compared to the base strain.


Onxy® and GenoScaler™

  • Onxy is a tool that has advanced synthetic biology by providing a complete bench-top solution to improve genetic engineering and process develop with applications in microbial, plant and mammalian systems.
  •  GenoScaler™is based on ultra-high-throughput CRISPR+ technologies and the principles of directed evolution, to manufacture and supply ingredients at scale.
  • The Inscripta platforms are moving forward the bioeconomy by transforming the R&D process, shortening development timelines, reducing costs, and increasing yields from biomanufacturing.

Sign up to join the BioP2P Network